XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (UNAUDITED) - USD ($)
$ in Thousands
Total
Total Charles River Laboratories, Inc. Equity
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning balance at Dec. 30, 2023 $ 56,722              
Increase (Decrease) in Temporary Equity                
Net income 1,201              
Other comprehensive income (loss), net of tax (2,763)              
Adjustment of redeemable noncontrolling interests to redemption value 4,807              
Dividends declared to noncontrolling interests (2,192)              
Ending balance at Mar. 30, 2024 57,775              
Beginning balance (in shares) at Dec. 30, 2023     51,338,000          
Beginning balance at Dec. 30, 2023 3,602,276 $ 3,596,882 $ 513 $ 1,905,578 $ 1,887,218 $ (196,427) $ 0 $ 5,394
Beginning balance (in shares) at Dec. 30, 2023             0  
Increase (Decrease) in Stockholders' Equity                
Net income 73,281 72,960     72,960     321
Other comprehensive income (loss), net of tax (53,492) (53,492)       (53,492)    
Adjustment of redeemable noncontrolling interests to redemption value (4,807) (4,807)   (4,406) (401)      
Issuance of stock under employee compensation plans (in shares)     214,000          
Issuance of stock under employee compensation plans 21,505 21,505 $ 2 21,503        
Purchase of treasury shares (in shares)             42,000  
Purchase of treasury shares (9,351) (9,351)         $ (9,351)  
Stock-based compensation 16,738 16,738   16,738        
Ending balance (in shares) at Mar. 30, 2024     51,552,000          
Ending balance at Mar. 30, 2024 3,646,150 3,640,435 $ 515 1,939,413 1,959,777 (249,919) $ (9,351) 5,715
Ending balance (in shares) at Mar. 30, 2024             42,000  
Beginning balance at Dec. 30, 2023 56,722              
Ending balance at Jun. 29, 2024 46,076              
Beginning balance (in shares) at Dec. 30, 2023     51,338,000          
Beginning balance at Dec. 30, 2023 3,602,276 3,596,882 $ 513 1,905,578 1,887,218 (196,427) $ 0 5,394
Beginning balance (in shares) at Dec. 30, 2023             0  
Ending balance (in shares) at Jun. 29, 2024     51,696,000          
Ending balance at Jun. 29, 2024 3,727,018 3,722,729 $ 517 1,956,629 2,053,557 (269,709) $ (18,265) 4,289
Ending balance (in shares) at Jun. 29, 2024             83,000  
Beginning balance at Mar. 30, 2024 57,775              
Increase (Decrease) in Temporary Equity                
Net income (332)              
Other comprehensive income (loss), net of tax 85              
Adjustment of redeemable noncontrolling interests to redemption value 496              
Purchase of remaining equity interest of other redeemable noncontrolling interest (12,000)              
Adjustment of purchase price of Noveprim redeemable noncontrolling interest 52              
Ending balance at Jun. 29, 2024 46,076              
Beginning balance (in shares) at Mar. 30, 2024     51,552,000          
Beginning balance at Mar. 30, 2024 3,646,150 3,640,435 $ 515 1,939,413 1,959,777 (249,919) $ (9,351) 5,715
Beginning balance (in shares) at Mar. 30, 2024             42,000  
Increase (Decrease) in Stockholders' Equity                
Net income 94,593 94,081     94,081     512
Other comprehensive income (loss), net of tax (19,790) (19,790)       (19,790)    
Adjustment of redeemable noncontrolling interests to redemption value (496) (496)   (195) (301)      
Dividends declared to noncontrolling interests (1,938)             (1,938)
Issuance of stock under employee compensation plans (in shares)     144,000          
Issuance of stock under employee compensation plans 826 826 $ 2 824        
Purchase of treasury shares (in shares)             41,000  
Purchase of treasury shares (8,914) (8,914)         $ (8,914)  
Stock-based compensation 16,587 16,587   16,587        
Ending balance (in shares) at Jun. 29, 2024     51,696,000          
Ending balance at Jun. 29, 2024 3,727,018 3,722,729 $ 517 1,956,629 2,053,557 (269,709) $ (18,265) 4,289
Ending balance (in shares) at Jun. 29, 2024             83,000  
Beginning balance at Dec. 28, 2024 41,126              
Increase (Decrease) in Temporary Equity                
Net income 75              
Other comprehensive income (loss), net of tax (858)              
Adjustment of redeemable noncontrolling interests to redemption value 1,320              
Ending balance at Mar. 29, 2025 $ 41,663              
Beginning balance (in shares) at Dec. 28, 2024 51,141,000   51,141,000          
Beginning balance at Dec. 28, 2024 $ 3,466,952 3,461,503 $ 511 1,966,237 1,812,100 (317,345) $ 0 5,449
Beginning balance (in shares) at Dec. 28, 2024 0           0  
Increase (Decrease) in Stockholders' Equity                
Net income $ 25,803 25,469     25,469     334
Other comprehensive income (loss), net of tax 52,099 52,099       52,099    
Adjustment of redeemable noncontrolling interests to redemption value (1,320) (1,320)   (1,320)        
Issuance of stock under employee compensation plans (in shares)     60,000          
Issuance of stock under employee compensation plans 1 1 $ 1          
Purchase of treasury shares (in shares)             2,086,000  
Purchase of treasury shares (353,132) (353,132)         $ (353,132)  
Share repurchase excise tax (3,419) (3,419)         (3,419)  
Stock-based compensation 13,135 13,135   13,135        
Ending balance (in shares) at Mar. 29, 2025     51,201,000          
Ending balance at Mar. 29, 2025 3,200,119 3,194,336 $ 512 1,978,052 1,837,569 (265,246) $ (356,551) 5,783
Ending balance (in shares) at Mar. 29, 2025             2,086,000  
Beginning balance at Dec. 28, 2024 41,126              
Ending balance at Jun. 28, 2025 $ 39,956              
Beginning balance (in shares) at Dec. 28, 2024 51,141,000   51,141,000          
Beginning balance at Dec. 28, 2024 $ 3,466,952 3,461,503 $ 511 1,966,237 1,812,100 (317,345) $ 0 5,449
Beginning balance (in shares) at Dec. 28, 2024 0           0  
Ending balance (in shares) at Jun. 28, 2025 49,209,000   51,344,000          
Ending balance at Jun. 28, 2025 $ 3,359,630 3,353,321 $ 513 1,992,718 1,889,895 (166,467) $ (363,338) 6,309
Ending balance (in shares) at Jun. 28, 2025 2,136,000           2,136,000  
Beginning balance at Mar. 29, 2025 $ 41,663              
Increase (Decrease) in Temporary Equity                
Net income (159)              
Other comprehensive income (loss), net of tax 2,527              
Adjustment of redeemable noncontrolling interests to redemption value 2,383              
Dividends declared to noncontrolling interests (6,458)              
Ending balance at Jun. 28, 2025 39,956              
Beginning balance (in shares) at Mar. 29, 2025     51,201,000          
Beginning balance at Mar. 29, 2025 3,200,119 3,194,336 $ 512 1,978,052 1,837,569 (265,246) $ (356,551) 5,783
Beginning balance (in shares) at Mar. 29, 2025             2,086,000  
Increase (Decrease) in Stockholders' Equity                
Net income 52,852 52,326     52,326     526
Other comprehensive income (loss), net of tax 98,779 98,779       98,779    
Adjustment of redeemable noncontrolling interests to redemption value (2,383) (2,383)   (2,383)        
Issuance of stock under employee compensation plans (in shares)     143,000          
Issuance of stock under employee compensation plans 1 1 $ 1          
Purchase of treasury shares (in shares)             50,000  
Purchase of treasury shares (6,787) (6,787)         $ (6,787)  
Stock-based compensation $ 17,049 17,049   17,049        
Ending balance (in shares) at Jun. 28, 2025 49,209,000   51,344,000          
Ending balance at Jun. 28, 2025 $ 3,359,630 $ 3,353,321 $ 513 $ 1,992,718 $ 1,889,895 $ (166,467) $ (363,338) $ 6,309
Ending balance (in shares) at Jun. 28, 2025 2,136,000           2,136,000